DEXA Bone Density Analysis of the CoreHip® Prosthesis System

ConditionsPrimary Osteoarthritis Cartilage Degeneration Osteoarthritis, Hip Inflammatory Arthritis Osteonecrosis of Femoral Head Traumatic Disorder

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age35-85

SponsorAesculap AG

About this trial

The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.

Eligibility criteria

Qualifiers

Unilateral hip osteoarthritis

Indication for CoreHip Standard hip stem according to preoperative planning

Written Informed Consent

Age 35-85 years

Disqualifiers

Femoral neck fractures

Pregnancy

BMI > 35

History of femoral fracture or previous surgery on the same hip

Trial design

Treatments tested in this trial

Primary hip replacement with cementless stem

Treatment groups

40 Participants

are divided into 1 treatment group

Sponsors and collaborators

Aesculap AG

Lead sponsor

Source ClinicalTrials.gov